ArticlePloS one2025
Oxidized dextran coated magnetic nanoparticles to develop magnetic cross-linked Bacillus lehensis G1 endolevanase aggregates for levan-type fructooligosaccharides synthesis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endolevanase from Bacillus lehensis G1 (rlevblg1) is an enzyme that hydrolyzes levan for the production of levan-type fructooligosaccharides (L-FOS). To maximize the industrial utility of enzymes, it is essential to find effective immobilization techniques that preserve their activity and stability. This study introduced the use of in silico analysis to predict the attachment site in order to perform site-directed cross-linking and develop efficient magnetic cross-linked enzyme aggregates (M-CLEAs). According to the computational analysis, dextran with aldehyde groups has attached far from the active site of rlevblg1 compared to dextran with acetyl functional groups. Oxidized dextran (Odex) was prepared and used to coat the magnetic nanoparticles (MNPs). The coated-MNPs (OdexM) exhibited super-paramagnetic behavior (78.9 emu/g), which was applied to develop M-CLEAs of rlevblg1. The biocatalyst (rlevblg1-OdexM-CLEAs) was easily separated from the reaction medium and acquired a recovered activity of 74.7%, maintaining substrate affinity similar to that of the free enzyme. Moreover, rlevblg1-OdexM-CLEAs exhibited great mechanical stability and potential reusability for 10 cycles with more than 50% recovered activity up to the 5th cycle. The optimum temperature of rlevblg1-OdexM-CLEAs has shifted from 30 to 40 °C resulting in a significant improvement in the thermal stability which was 8.9-fold higher than that of free rlevblg1 after 1 h of incubation at 40 °C. After 8 min of incubation at 45 °C, the activity recovery of free rlevblg1 was completely lost, whereas rlevblg1-OdexM-CLEAs retained almost 20% of its initial activity recovery. In addition to the enhanced operational characteristics, M-CLEAs of rlevblg1 hydrolyzed levan into a high yield of L-FOS, proving the suitability of rlevblg1-OdexM-CLEAs as a biocatalyst for industrial production of L-FOS from levan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.